Literature DB >> 11524236

Granulosa cells of the cumulus oophorus are different from mural granulosa cells in their response to gonadotrophins and IGF-I.

F Khamsi1, S Roberge.   

Abstract

There are two types of granulosa cells: those which surround the oocyte are cumulus cells (CC) and those which surround the antrum are mural granulosa cells (MGC). These cells are under the influence of several hormones and growth factors, the most important of which are gonadotrophins and IGF-I. In this article, we report novel observations on the differences between these two types of granulosa cells and their interaction with gonadotrophins and IGF-I. We were able to conduct physiological studies on the role of IGF-I by using an analogue of IGF-I which does not bind to IGF-I-binding proteins (LR3-IGF-I). Immature rats received saline, equine chorionic gonadotrophin (eCG), LR3-IGF-I or eCG plus LR3-IGF-I by infusion using a pump from 24-29 days of age. The rats were killed and the ovaries removed. Surface follicles were punctured and MGC and oocyte cumulus complexes were removed. These were cultured in saline (control) and in three different doses of FSH. Cell replication was assessed by 3H-thymidine incorporation and differentiation was evaluated by the measurement of progesterone secretion. It was noted that CC replicated ten times more than MGC. Similarly, progesterone secretion by CC was six times more than by MGC. In vivo exposure to gonadotrophins (eCG) positively influenced in vitro treatment with FSH in both cell types. This phenomenon was observed in both cell replication and progesterone secretion. The IGF-I analogue had a positive effect on cell replication of MGC but a negative effect on the cell replication of CC. With respect to progesterone secretion, the IGF-I analogue had a negative effect on CC but a positive effect on MGC. In conclusion, CC behaved differently from MGC in response to gonadotrophins and the IGF-I analogue. IGF-I and FSH acted additively, synergistically or antagonistically in different circumstances.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524236     DOI: 10.1677/joe.0.1700565

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Effect of interrupted endogenous BMP/Smad signaling on growth and steroidogenesis of porcine granulosa cells.

Authors:  Wei Wang; Li Wang; Xin-xiu Li; Xia Chen; Hai-yan Zhang; Yu He; Jing-jing Wang; Yong-yan Zhao; Bao-le Zhang; Yin-xue Xu
Journal:  J Zhejiang Univ Sci B       Date:  2010-09       Impact factor: 3.066

2.  Rhesus monkey cumulus cells revert to a mural granulosa cell state after an ovulatory stimulus.

Authors:  Charles L Chaffin; Young S Lee; Catherine A VandeVoort; Bela G Patel; Keith E Latham
Journal:  Endocrinology       Date:  2012-09-24       Impact factor: 4.736

Review 3.  Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis.

Authors:  F Khamsi; S Roberge; Y Yavas; I C Lacanna; X Zhu; J Wong
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

4.  Granulosa cell apoptosis induced by a novel FSH binding inhibitory peptide from human ovarian follicular fluid.

Authors:  Swati S Chitnis; Rajshri M Navlakhe; Gayatri C Shinde; Sharmila J Barve; Serena D'Souza; Smita D Mahale; Tarala D Nandedkar
Journal:  J Histochem Cytochem       Date:  2008-07-21       Impact factor: 2.479

5.  Muscle Cell Morphogenesis, Structure, Development and Differentiation Processes Are Significantly Regulated during Human Ovarian Granulosa Cells In Vitro Cultivation.

Authors:  Claudia Dompe; Wiesława Kranc; Karol Jopek; Katarzyna Kowalska; Sylwia Ciesiółka; Błażej Chermuła; Artur Bryja; Maurycy Jankowski; Joanna Perek; Małgorzata Jozkowiak; Lisa Moncrieff; Greg Hutchings; Krzysztof Janowicz; Leszek Pawelczyk; Małgorzata Bruska; James Petitte; Paul Mozdziak; Magdalena Kulus; Hanna Piotrowska-Kempisty; Robert Z Spaczyński; Michał Nowicki; Bartosz Kempisty
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.